Status:
NOT_YET_RECRUITING
Effects of Oxaliplatin-Induced Peripheral Neuropathy on Hand Function, Grip Strength and Quality of Life in Colorectal Cancer Patients
Lead Sponsor:
Fenerbahce University
Collaborating Sponsors:
Acibadem University
Conditions:
Peripheral Neuropathy Due to Chemotherapy
Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients
Eligibility:
All Genders
20+ years
Brief Summary
The aim of this study is to investigate the effects of oxaliplatin-induced peripheral neuropathy on hand function, grip strength, and quality of life in colorectal cancer patients. Assessing the motor...
Detailed Description
Oxaliplatin is a chemotherapy drug frequently used in the treatment of colorectal cancers, the third most common type of cancer. However, oxaliplatin is associated with long-term neurotoxicity, the mo...
Eligibility Criteria
Inclusion
- Receiving chemotherapy due to a diagnosis of locally advanced or metastatic colorectal cancer,
- Having received at least 3 cycles of single or combined oxaliplatin-based chemotherapy,
- Aged 20 years or older,
- No speech or hearing impairments,
- Voluntary participation in the study.
Exclusion
- Development of peripheral neuropathy due to causes other than chemotherapy (e.g., tumor compression, nutritional disorders, infections, or major systemic diseases such as diabetes mellitus),
- Presence of mental or cooperation problems.
Key Trial Info
Start Date :
September 24 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 24 2026
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT07203066
Start Date
September 24 2025
End Date
February 24 2026
Last Update
October 2 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.